The content of the cell suspensions used in bone marrow transplantation can vary by at least twelvefold in the ratio of bone marrow-derived to blood-derived cells. The ratio is somewhat higher in young donors but is similar for male and female donors and is not closely correlated with the incidence of graft v host reactions.
In bone marrow transplantation in man, a mixture of blood and marrow is aspirated from the donor and injected intravenously to the recipient. To obtain enough cells (usually considered to be > 2 x 108/kg body weight) the volume of aspirate must approach one litre, of which it can be assumed that 980% or so is actually blood and less than 20% is derived from the marrow itself. This cell mixture is in sharp contrast with that used in marrow transplants in mice, where femoral marrow cells form an inoculum which is virtually free of blood contamination. Furthermore, it is an old observation that in mice graft v host (GvH) reactions are relatively uncommon and difficult to induce by such marrow suspensions, whereas the addition of blood, lymph node or spleen cells greatly enhances the incidence and severity of GvH reactions.1 Similar observations in dogs and other species confirm the general validity of the hypothesis that it is cells from the blood presumptively T lymphocytes-which are the precipitating cause of GvH disease.2 3 What is not known is the actual composition of the blood-marrow mixture in human transplants and whether it is related to GvH disease. In particular, the increased susceptibility to GvH disease if the donor is female-irrespective of the recipient sex4-might result from differences in the content of the donor inoculum perhaps because Analysing the adult donors separately (age 22 yr and over) it can be seen that the ratio of bonemarrow cells to blood-derived cells varies from 0 4 to 5-1 and that the mean ratio for 10 females is higher (2 32) than for 22 males (2 02). The ratio for younger donors (< 22 yr) is somewhat higher (2-85) as might be expected from the greater cellularity of young bone-marrow and the rather smaller quantity of aspirate.
There is no close correlation in this series between of male marrows these in addition to patients with nodular lymphoid hyperplasia (without lymphoma) where there were eight females against two males. Admittedly, the sample was mostly from an older age group than that from which bone marrow donors are recruited but it suggests a possible basis for the incidence of GvH disease in relation to donor sex.
In our study an attempt was made to count lymphoid cells in smears from the marrow suspensions but owing to morphological ambiguities this is an inaccurate procedure. The figures suggested that more lymphocytes were present than could be accounted for by the blood component but an analysis by section of particles or by specific lymphocyte markers would probably be more accurate. Current methods of marrow transplantation using antilymphocyte sera or lectins to remove lymphocytes might also indicate the basis of the sex difference in marrow transplants.
